Monitors 21-hydroxylase deficiency CAH treatment adequacy using 17-OHP, androstenedione, renin/aldosterone ratio, and growth parameters to optimize hydrocortisone and fludrocortisone dosing.
Monitors 21-hydroxylase deficiency CAH treatment adequacy using 17-OHP, androstenedione, renin/aldosterone ratio, and growth parameters to optimize hydrocortisone and fludrocortisone dosing
Each component has a specific meaning:
Note: Interpret the cah control monitor result against the thresholds and context described above.
Enter the 17-OHP, androstenedione, renin/aldosterone ratio, growth parameters for the scenario you are assessing. Monitors 21-hydroxylase deficiency CAH treatment adequacy using 17-OHP, androstenedione, renin/aldosterone ratio, and growth parameters to optimize hydrocortisone and fludrocortisone dosing. Use the cah control monitor result to inform your calculation.